Pko Investment Management Joint Stock CO Gilead Sciences, Inc. Transaction History
Pko Investment Management Joint Stock CO
- $931 Billion
- Q2 2025
A detailed history of Pko Investment Management Joint Stock CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 9,000 shares of GILD stock, worth $1.07 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
9,000
Previous 3,000
200.0%
Holding current value
$1.07 Million
Previous $336 Million
196.84%
% of portfolio
0.11%
Previous 0.04%
Shares
26 transactions
Others Institutions Holding GILD
# of Institutions
2,297Shares Held
1BCall Options Held
9.56MPut Options Held
9.96M-
Black Rock Inc. New York, NY121MShares$14.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$14 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.11 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.52 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.39 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...